About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 424 record(s)
Req # A-2022-000054
All material prepared by the Public Health Agency of Canada (PHAC) officials for the meeting between PHAC and the Office of the Privacy Commissioner (OPC) held on 22 April 2020, and of any after-meeting emails or document written by PHAC officials capturing what was discussed or agreed to at that meeting. Copy of the document capturing the determination decision made in September 2020.Organization: Health Canada
October 2022
Req # A-2022-000222
All documents related to Cannabis cultivation, production, research, importation, and exports with and between Jamaican cannabis companies / investments / investors / businesses. Results of any cannabis testing in Canadian Health Canada facilities or contracted facilities on cannabis products produced in Jamaica and communications with The Federal Skilled Worker Program (FSWP) and the Canadian Seasonal Agricultural Workers Programme for labour related to cannabis production.Organization: Health Canada
October 2022
Req # A-2022-000232
All records for the past 10 years for the position called Director General Controlled Substances Directorate Health Canada. The number / quantity of individuals holding this job title if more than one.Organization: Health Canada
October 2022
Req # A-2022-000338
Financial information on the Federally Funded Health Information systems in Canada. Total cost / expense broken down by year ending 2017, 2018, 2019, 2020 & 2021 for all money paid on: Federal Health Transfers to provinces. Federal Health IT Research systems. Federal Health data transfer/ collection/ management systems. Federal Payments & any known Provincial payments to Canada Health Infoway & separately services they have arranged. A total of all money transferred, granted, gifted to Canada Health Infoway from inception in 2001 to June 14th 2022.Organization: Health Canada
October 2022
Req # A-2022-000393
The initial cover letters indicating the brand name of the reference drug product and the dosage form of the generic drugs in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient micafungin. The Screening Acceptance Letters from Health Canada to the generic drug manufacturers confirming completion of screening of the Abbreviated New Drug Submissions (ANDS) for micafungin which appear in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22.Organization: Health Canada
October 2022
Req # A-2022-000463
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient tolvaptan. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for tolvaptan which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22.Organization: Health Canada
October 2022
Req # A-2022-000509
The Acknowledgment Letter that would address the most recent status of authorization by Health Canada for the medications named: Aducanumab et LecanemabOrganization: Health Canada
October 2022
Req # A-2022-000522
All test results for environmental impact of scented laundry products.Organization: Health Canada
October 2022
Req # A-2022-000554
All serious drug adverse reaction reports associated with remdesivir. Dates: 28 July 2020 to 4 August 2022.Organization: Health Canada
October 2022
Req # A-2022-000662
Information on all proceedings, claims or appeals currently active or pending or any balance due to you from this Company. Company: Boucherie Veilleux inc. NEQ 1162487467. 1000 Vachon Boulevard North, Sainte-Marie, QC G6E 1M2.Organization: Health Canada
October 2022